entinostat has been researched along with Leukemia, Myelomonocytic, Chronic in 1 studies
Leukemia, Myelomonocytic, Chronic: A myelodysplastic-myeloproliferative disease characterized by monocytosis, increased monocytes in the bone marrow, variable degrees of dysplasia, but an absence of immature granulocytes in the blood.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Entinostat is a histone deacetylase inhibitor that has been combined with AZA with significant clinical activity in a previous phase I dose finding study." | 2.79 | Prolonged administration of azacitidine with or without entinostat for myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes: results of the US Leukemia Intergroup trial E1905. ( Czader, M; Erba, HP; Figueroa, ME; Gabrilove, J; Gore, SD; Greenberg, PL; Herman, J; Juckett, M; Ketterling, R; Litzow, M; Malick, L; Melnick, A; Paietta, E; Prebet, T; Smith, MR; Sun, Z; Tallman, MS, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Prebet, T | 1 |
| Sun, Z | 1 |
| Figueroa, ME | 1 |
| Ketterling, R | 1 |
| Melnick, A | 1 |
| Greenberg, PL | 1 |
| Herman, J | 1 |
| Juckett, M | 1 |
| Smith, MR | 1 |
| Malick, L | 1 |
| Paietta, E | 1 |
| Czader, M | 1 |
| Litzow, M | 1 |
| Gabrilove, J | 1 |
| Erba, HP | 1 |
| Gore, SD | 1 |
| Tallman, MS | 1 |
1 trial available for entinostat and Leukemia, Myelomonocytic, Chronic
| Article | Year |
|---|---|
Prolonged administration of azacitidine with or without entinostat for myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes: results of the US Leukemia Intergroup trial E1905.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherap | 2014 |